Table 4.
Variable | Overall survival | Disease-free survival | Progression-free survival | |||
---|---|---|---|---|---|---|
|
|
|
||||
HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
Age, yr | 0.993 (0.979–1.007) | 0.31 | 1.022 (0.994–1.051) | 0.12 | 1.002 (0.979–1.025) | 0.90 |
| ||||||
Female v. male sex | 1.066 (0.748–1.520) | 0.72 | 0.751 (0.379–1.489) | 0.41 | 1.306 (0.779–2.190) | 0.31 |
| ||||||
Locally advanced v. early stage† | 3.291 (1.887–5.738) | < 0.001 | 4.313 (1.813–10.259) | < 0.001 | — | — |
| ||||||
Rural or remote v. urban or suburban residence | 0.622 (0.383–1.010) | 0.06 | 0.472 (0.186–1.200) | 0.12 | 0.536 (0.250–1.149) | 0.11 |
CI = confidence interval; HR = hazard ratio.
Clinical variables with a statistically significant difference between groups in univariate analysis were included in this model.
Not applicable for progression-free survival since all patients had locally advanced cancer.